FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Balow

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Procedures

Physiology

Lymphocyte Activation

Co-author Network

Publications

TOP 3
James E Balow; Beverly Barham; Matthew G Booty; Ariel Bulua; Jae Jin Chae; Raphaela Goldbach-Mansky; James Greene; Daniel L Kastner; John G Ryan; Deborah Stone; Hong-Wei Sun; Ivona Aksentijevich
Microarray-based gene expression profiling in patients with cryopyrin-associated periodic syndromes defines a disease-related signature and IL-1-responsive transcripts.
James E Balow
Glomerular disease: perspectives on maintenance therapy in lupus nephritis.
Dimitrios T Boumpas; George Bertsias; James E Balow
A decade of mycophenolate mofetil for lupus nephritis: is the glass half-empty or half-full?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Balow (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: James E Balow; Beverly Barham; Matthew G Booty; Ariel Bulua; Jae Jin Chae; Raphaela Goldbach-Mansky; James Greene; Daniel L Kastner; John G Ryan; Deborah Stone; Hong-Wei Sun; Ivona Aksentijevich
Microarray-based gene expression profiling in patients with cryopyrin-associated periodic syndromes defines a disease-related signature and IL-1-responsive transcripts.
Annals of the rheumatic diseases 2013;72(6):1064-70.
2012: James E Balow
Glomerular disease: perspectives on maintenance therapy in lupus nephritis.
Nature reviews. Nephrology 2012;8(3):136-8.
2010: Dimitrios T Boumpas; George Bertsias; James E Balow
A decade of mycophenolate mofetil for lupus nephritis: is the glass half-empty or half-full?
Annals of the rheumatic diseases 2010;69(12):2059-61.
2010: Gabor G Illei; Yuko Shirota; Cheryl H Yarboro; Jimmy Daruwalla; Edward Tackey; Kazuki Takada; Thomas Fleisher; James E Balow; Peter E Lipsky
Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.
Arthritis and rheumatism 2010;62(2):542-52.
2009: Howard A Austin; Gabor G Illei; Michelle J Braun; James E Balow
Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy.
Journal of the American Society of Nephrology : JASN 2009;20(4):901-11.
2008: Hua Zhou; Anita Cheruvanky; Xuzhen Hu; Takayuki Matsumoto; Noriyuki Hiramatsu; Monique E Cho; Alexandra Berger; Asada Leelahavanichkul; Kent Doi; Lakhmir S Chawla; Gabor G Illei; Jeffrey B Kopp; James E Balow; HA Austin; Peter S T Yuen; robert star
Urinary exosomal transcription factors, a new class of biomarkers for renal disease.
Kidney international 2008;74(5):613-21.
2008: Rachel Elizabeth Rau; Courtney D Fitzhugh; Kristin Baird; Karoll J Cortez; Li Li; Steven H Fischer; Edward W Cowen; James E Balow; THOMAS WALSH; Jeffrey I Cohen; ALAN WAYNE
Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapy.
The Pediatric infectious disease journal 2008;27(3):265-8.
2007: Gabor G Illei; Cheryl H Yarboro; Takashi Kuroiwa; Ryan Schlimgen; HA Austin; J F Tisdale; P Chitkara; Thomas A Fleisher; JOHN KLIPPEL; James E Balow; Dimitrios T Boumpas
Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
Rheumatology (Oxford, England) 2007;46(6):952-6.
2006: Carla Musso; Edward D Javor; Elaine Cochran; James E Balow; Phillip Gorden
Spectrum of renal diseases associated with extreme forms of insulin resistance.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(4):616-22.
2005: Ramaprasad Srinivasan; James E Balow; Sharda G Sabnis; Andreas Lundqvist; Takehito Igarashi; Yoshiyuki Takahashi; Howard A Austin; John F Tisdale; John Barrett; Nancy Geller; Richard Childs
Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation.
British journal of haematology 2005;131(1):74-9.
2005: A Addo; J Le; W Li; Ivona Aksentijevich; James E Balow; A Lee; P K Gregersen; Daniel Kastner; Elaine F Remmers
Analysis of CARD15/NOD2 haplotypes fails to identify common variants associated with rheumatoid arthritis susceptibility.
Scandinavian journal of rheumatology 2005;34(3):198-203.
2005: James E Balow
Nephropathy in the context of HIV infection.
Kidney international 2005;67(4):1632-3.
2005: James E Balow
Clinical presentation and monitoring of lupus nephritis.
Lupus 2005;14(1):25-30.
2004: Kazuki Takada; Million Arefayene; Zeruesenay Desta; Cheryl H Yarboro; Dimitrios T Boumpas; James E Balow; David A Flockhart; Gabor G Illei
Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.
Arthritis and rheumatism 2004;50(7):2202-10.
2004: Edward D Javor; Stephanie Ann Moran; Janice Ryan Young; Elaine Cochran; Alex M DePaoli; Elif Arioglu Oral; Martin A Turman; Piers R Blackett; David B Savage; Stephen O'Rahilly; James E Balow; Phillip Gorden
Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy.
The Journal of clinical endocrinology and metabolism 2004;89(7):3199-207.
2004: James E Balow; Howard A Austin
Maintenance therapy for lupus nephritis--something old, something new.
The New England journal of medicine 2004;350(10):1044-6.
2004: James E Balow; Howard A Austin
Treatment of proliferative lupus nephritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(2):383-5.
2004: Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; GARY HILL; Prue Hill; John Jennette; Norella Chiew-Tong Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
The classification of glomerulonephritis in systemic lupus erythematosus revisited.
Journal of the American Society of Nephrology : JASN 2004;15(2):241-50.
2004: Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; GARY HILL; Prue Hill; John Jennette; Norella Chiew-Tong Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
The classification of glomerulonephritis in systemic lupus erythematosus revisited.
Kidney international 2004;65(2):521-30.
2003: Susan F Leitman; John F Tisdale; Charles D Bolan; Mark A Popovsky; JOHN KLIPPEL; James E Balow; Dimitrios T Boumpas; Gabor G Illei
Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus.
Transfusion 2003;43(12):1667-71.
2003: James E Balow; Howard A Austin
Therapy of membranous nephropathy in systemic lupus erythematosus.
Seminars in nephrology 2003;23(4):386-91.
2003: Carol A Langford; James E Balow
New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney.
Current opinion in nephrology and hypertension 2003;12(3):267-72.
2003: Dimitrios T Boumpas; Richard Furie; Susan Manzi; Gabor G Illei; Daniel J Wallace; James E Balow; Akshay Vaishnaw
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.
Arthritis and rheumatism 2003;48(3):719-27.
2002: James E Balow
Choosing treatment for proliferative lupus nephritis.
Arthritis and rheumatism 2002;46(8):1981-3.
2002: Keith M Hull; Daniel Kastner; James E Balow
Hereditary periodic fever.
The New England journal of medicine 2002;346(18):1415-6; author reply 1415-6.
2002: Gabor G Illei; Kazuki Takada; D Parkin; HA Austin; M Crane; Cheryl H Yarboro; EM Vaughan; Takashi Kuroiwa; Carol L Danning; JA Pando; A D Steinberg; Mark Gourley; JOHN KLIPPEL; James E Balow; Dimitrios T Boumpas
Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.
Arthritis and rheumatism 2002;46(4):995-1002.
2002: Mary H Branton; Raphael Schiffmann; Sharda G Sabnis; Gary J Murray; Jane M Quirk; Gheona Altarescu; Lev G Goldfarb; Roscoe O Brady; James E Balow; Howard A Austin Iii; Jeffrey B Kopp
Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course.
Medicine 2002;81(2):122-38.
2001: Gabor G Illei; HA Austin; M Crane; L Collins; Mark Gourley; Cheryl H Yarboro; EM Vaughan; Takashi Kuroiwa; Carol L Danning; A D Steinberg; JOHN KLIPPEL; James E Balow; Dimitrios T Boumpas
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.
Annals of internal medicine 2001;135(4):248-57.
2001: Raphael Schiffmann; Jeffrey B Kopp; Howard A Austin; Sharda G Sabnis; David F Moore; Thais Weibel; James E Balow; Roscoe O Brady
Enzyme replacement therapy in Fabry disease: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;285(21):2743-9.
2000: M T Collins; A T Remaley; Gyorgy Csako; Frank Pucino; Monica C Skarulis; James E Balow; Nicholas Sarlis
Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome.
Journal of endocrinological investigation 2000;23(6):383-92.
2000: Howard A Austin; James E Balow
Treatment of lupus nephritis.
Seminars in nephrology 2000;20(3):265-76.
2000: James E Balow; Howard A Austin
Progress in the treatment of proliferative lupus nephritis.
Current opinion in nephrology and hypertension 2000;9(2):107-15.
2000: James E Balow; Dimitrios T Boumpas; H A Austin
New prospects for treatment of lupus nephritis.
Seminars in nephrology 2000;20(1):32-9.
1999: Dimitrios T Boumpas; Ioannis Tassiulas; Thomas A Fleisher; E Vaughan; S Piscitelli; Y Kim; Frank Pucino; James E Balow; HA Austin
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
Clinical nephrology 1999;52(2):67-75.
1999: John C Davis; S Manzi; Cheryl H Yarboro; JE Rairie; Iain B McInnes; D Averthelyi; D Sinicropi; V G Hale; James E Balow; HA Austin; Dimitrios T Boumpas; JOHN KLIPPEL
Recombinant human Dnase I (rhDNase) in patients with lupus nephritis.
Lupus 1999;8(1):68-76.
1999: Howard A Austin; James E Balow
Natural history and treatment of lupus nephritis.
Seminars in nephrology 1999;19(1):2-11.
1998: Ioannis Tassiulas; Ivona Aksentijevich; J E Salmon; Y Kim; Cheryl H Yarboro; EM Vaughan; John C Davis; D L Scott; HA Austin; JOHN KLIPPEL; James E Balow; Mark Gourley; Dimitrios T Boumpas
Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patients.
Clinical nephrology 1998;50(1):8-13.
1998: Carol A Langford; JOHN KLIPPEL; James E Balow; Stephen P James; michael sneller
Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity.
Annals of internal medicine 1998;129(1):49-58.
1998: Carol A Langford; JOHN KLIPPEL; James E Balow; Stephen P James; michael sneller
Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 1: rheumatologic and renal diseases.
Annals of internal medicine 1998;128(12 Pt 1):1021-8.
1998: John C Davis; HA Austin; Dimitrios T Boumpas; Thomas A Fleisher; Cheryl H Yarboro; A Larson; James E Balow; JOHN KLIPPEL; D Scott
A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis.
Arthritis and rheumatism 1998;41(2):335-43.
1998: E Pras; Avi Livneh; James E Balow; E Pras; Daniel Kastner; Mordechai Pras; P Langevitz
Clinical differences between North African and Iraqi Jews with familial Mediterranean fever.
American journal of medical genetics 1998;75(2):216-9.
1998: Dimitrios T Boumpas; James E Balow
Outcome criteria for lupus nephritis trials: a critical overview.
Lupus 1998;7(9):622-9.
1997: James E Balow; DA Shelton; A Orsborn; Marie Mangelsdorf; Ivona Aksentijevich; T Blake; R Sood; D Gardner; R Liu; Elon Pras; E N Levy; Michael Centola; Z Deng; Nurit Zaks; Geryl Wood; Xian Chen; Neil Richards; M Shohat; Avi Livneh; Mordechai Pras; Norman A Doggett; Francis S Collins; P Paul Liu; J I Rotter; Daniel Kastner
A high-resolution genetic map of the familial Mediterranean fever candidate region allows identification of haplotype-sharing among ethnic groups.
Genomics 1997;44(3):280-91.
1997: R Sood; T Blake; Ivona Aksentijevich; Geryl Wood; Xian Chen; D Gardner; DA Shelton; Marie Mangelsdorf; A Orsborn; Elon Pras; James E Balow; Michael Centola; Z Deng; Nurit Zaks; X Chen; Neil Richards; N Fischel-Ghodsian; J I Rotter; Mordechai Pras; M Shohat; LL Deaven; Deborah L Gumucio; David F Callen; Robert I Richards; Norman A Doggett
Construction of a 1-Mb restriction-mapped cosmid contig containing the candidate region for the familial Mediterranean fever locus (MEFV) on chromosome 16p 13.3.
Genomics 1997;42(1):83-95.
1997: H A Austin; A D Patel; C A Cadena; Dimitrios T Boumpas; James E Balow
Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.
The Journal of rheumatology 1997;24(1):61-8.
1996: B J Fessler; F Paliogianni; N Hama; James E Balow; Dimitrios T Boumpas
Glucocorticoids modulate CD28 mediated pathways for interleukin 2 production in human T cells: evidence for posttranscriptional regulation.
Transplantation 1996;62(8):1113-8.
1996: Mark Gourley; HA Austin; D Scott; Cheryl H Yarboro; E M Vaughan; J Muir; Dimitrios T Boumpas; JOHN KLIPPEL; James E Balow; A D Steinberg
Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.
Annals of internal medicine 1996;125(7):549-57.
1996: E N Levy; Y Shen; A Kupelian; L Kruglyak; Ivona Aksentijevich; Elon Pras; James E Balow; B Linzer; X Chen; DA Shelton; Deborah L Gumucio; Mordechai Pras; M Shohat; J I Rotter; Nathan Fischel-Ghodsian; Robert I Richards; Daniel Kastner
Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246.
American journal of human genetics 1996;58(3):523-34.
1996: S M Dawisha; Cheryl H Yarboro; E M Vaughan; HA Austin; James E Balow; JOHN KLIPPEL
Outpatient monthly oral bolus cyclophosphamide therapy in systemic lupus erythematosus.
The Journal of rheumatology 1996;23(2):273-8.
1996: James E Balow; Dimitrios T Boumpas; B J Fessler; HA Austin
Management of lupus nephritis.
Kidney international. Supplement 1996;53():S88-92.
1995: Seema Ahuja; S Shrivastav; David Danielpour; James E Balow; Dimitrios T Boumpas
Regulation of transforming growth factor-beta 1 and its receptor by cyclosporine in human T lymphocytes.
Transplantation 1995;60(7):718-23.
1995: F Paliogianni; N Hama; James E Balow; M A Valentine; Dimitrios T Boumpas
Glucocorticoid-mediated regulation of protein phosphorylation in primary human T cells. Evidence for induction of phosphatase activity.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(4):1809-17.
1995: Dimitrios T Boumpas; B J Fessler; HA Austin; James E Balow; JOHN KLIPPEL; M D Lockshin
Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis.
Annals of internal medicine 1995;123(1):42-53.
1995: Dimitrios T Boumpas; HA Austin; B J Fessler; James E Balow; JOHN KLIPPEL; M D Lockshin
Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease.
Annals of internal medicine 1995;122(12):940-50.
1995: HA Austin; Dimitrios T Boumpas; E M Vaughan; James E Balow
High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(9):1620-8.
1994: HA Austin; Dimitrios T Boumpas; E M Vaughan; James E Balow
Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data.
Kidney international 1994;45(2):544-50.
1993: Dimitrios T Boumpas; George Chrousos; Ronald L Wilder; T R Cupps; James E Balow
Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates.
Annals of internal medicine 1993;119(12):1198-208.
1993: F Paliogianni; Seema Ahuja; J P Balow; James E Balow; Dimitrios T Boumpas
Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(8):4081-9.
1993: Dimitrios T Boumpas; HA Austin; E M Vaughan; Cheryl H Yarboro; JOHN KLIPPEL; James E Balow
Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy.
Annals of internal medicine 1993;119(5):366-9.
1993: Ivona Aksentijevich; L Gruberg; Elon Pras; James E Balow; M Kovo; E Gazit; M Dean; Mordechai Pras; Daniel Kastner
Evidence for linkage of the gene causing familial Mediterranean fever to chromosome 17q in non-Ashkenazi Jewish families: second locus or type I error?
Human genetics 1993;91(6):527-34.
1993: Seema Ahuja; F Paliogianni; H Yamada; James E Balow; Dimitrios T Boumpas
Effect of transforming growth factor-beta on early and late activation events in human T cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(8 Pt 1):3109-18.
1992: Dimitrios T Boumpas; HA Austin; E M Vaughn; JOHN KLIPPEL; A D Steinberg; Cheryl H Yarboro; James E Balow
Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.
Lancet 1992;340(8822):741-5.
1992: Elon Pras; Ivona Aksentijevich; L Gruberg; James E Balow; L Prosen; M Dean; A D Steinberg; Mordechai Pras; Daniel Kastner
Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16.
The New England journal of medicine 1992;326(23):1509-13.
1992: HA Austin; T T Antonovych; K MacKay; Dimitrios T Boumpas; James E Balow
NIH conference. Membranous nephropathy.
Annals of internal medicine 1992;116(8):672-82.
1991: Dimitrios T Boumpas; F Paliogianni; E D Anastassiou; James E Balow
Glucocorticosteroid action on the immune system: molecular and cellular aspects.
Clinical and experimental rheumatology 1991;9(4):413-23.
1991: Dimitrios T Boumpas; E D Anastassiou; S A Older; G C Tsokos; D L Nelson; James E Balow
Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription.
The Journal of clinical investigation 1991;87(5):1739-47.
1991: James E Balow
Kidney disease in systemic lupus erythematosus.
Rheumatology international 1991;11(3):113-5.
1990: Dimitrios T Boumpas; E D Anastassiou; G C Tsokos; G Thyphronitis; James E Balow
Gene transcription during in vitro activation of human B lymphocytes with Staphylococcus aureus Cowan I strain.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(8):2701-5.
1990: Dimitrios T Boumpas; S Barez; JOHN KLIPPEL; James E Balow
Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus.
Annals of internal medicine 1990;112(9):674-7.
1990: Dimitrios T Boumpas; M S Wheby; E S Jaffe; A D Steinberg; JOHN KLIPPEL; James E Balow
Synovitis in angioimmunoblastic lymphadenopathy with dysproteinemia simulating rheumatoid arthritis.
Arthritis and rheumatism 1990;33(4):578-82.
1990: Stanley R Pillemer; G C Tsokos; S A Barbieri; James E Balow; B Golding
The CR2 receptor (CD21) shows increased expression in the more differentiated cells of an antigen-specific B cell line.
Cellular immunology 1990;125(2):386-95.
1990: Dimitrios T Boumpas; E G Eleftheriades; R Molina; S Barez; J Atkinson; S A Older; James E Balow; G C Tsokos
c-myc proto-oncogene expression in peripheral blood mononuclear cells from patients with primary Sjögren's syndrome.
Arthritis and rheumatism 1990;33(1):49-56.
1990: Dimitrios T Boumpas; N J Patronas; M C Dalakas; C A Hakim; JOHN KLIPPEL; James E Balow
Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature.
The Journal of rheumatology 1990;17(1):89-92.
1990: James E Balow
Treatment and monitoring of patients with lupus nephritis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1990;5 Suppl 1():58-9.
1989: E G Eleftheriades; Dimitrios T Boumpas; James E Balow; G C Tsokos
Transcriptional and post-transcriptional mechanisms are responsible for the increased expression of c-myc protooncogene in lymphocytes from patients with systemic lupus erythematosus.
Clinical immunology and immunopathology 1989;52(3):507-15.
1989: T T Antonovych; S G Sabnis; S M Tuur; Isabell A Sesterhenn; James E Balow
Morphologic differences between polyarteritis and Wegener's granulomatosis using light, electron and immunohistochemical techniques.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1989;2(4):349-59.
1989: M E Cronin; James E Balow; G C Tsokos
Immunoglobulin deficiency in patients with systemic lupus erythematosus.
Clinical and experimental rheumatology 1989;7(4):359-64.
1989: HA Austin; A G Palestine; S G Sabnis; James E Balow; H G Preuss; Robert B Nussenblatt; T T Antonovych
Evolution of ciclosporin nephrotoxicity in patients treated for autoimmune uveitis.
American journal of nephrology 1989;9(5):392-402.
1989: James E Balow
Lupus nephritis: pathogenesis, course and management.
Advances in experimental medicine and biology 1989;252():3-15.
1988: James E Balow
Lupus as a renal disease.
Hospital practice (Office ed.) 1988;23(10):129-35, 139-40, 142-6.
1988: T T Antonovych; S G Sabnis; HA Austin; A G Palestine; James E Balow; Robert B Nussenblatt; G B Helfrich; ML Foegh; M R Alijani
Cyclosporine A-induced arteriolopathy.
Transplantation proceedings 1988;20(3 Suppl 3):951-8.
1988: James E Balow; HA Austin
Renal disease in systemic lupus erythematosus.
Rheumatic diseases clinics of North America 1988;14(1):117-33.
1988: Stanley R Pillemer; HA Austin; G C Tsokos; James E Balow
Lupus nephritis: association between serology and renal biopsy measures.
The Journal of rheumatology 1988;15(2):284-8.
1988: James E Balow
The nephropathy of systemic lupus erythematosus.
In vivo (Athens, Greece) 1988;2(1):111-4.
1987: JOHN KLIPPEL; HA Austin; James E Balow; N G leRiche; A D Steinberg; Paul H Plotz; J L Decker
Studies of immunosuppressive drugs in the treatment of lupus nephritis.
Rheumatic diseases clinics of North America 1987;13(1):47-56.
1987: James E Balow; HA Austin; G C Tsokos; T T Antonovych; A D Steinberg; JOHN KLIPPEL
NIH conference. Lupus nephritis.
Annals of internal medicine 1987;106(1):79-94.
1986: A G Palestine; HA Austin; James E Balow; T T Antonovych; S G Sabnis; H G Preuss; Robert B Nussenblatt
Renal histopathologic alterations in patients treated with cyclosporine for uveitis.
The New England journal of medicine 1986;314(20):1293-8.
1986: HA Austin; JOHN KLIPPEL; James E Balow; N G le Riche; A D Steinberg; Paul H Plotz; J L Decker
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
The New England journal of medicine 1986;314(10):614-9.
1985: J P Johnson; J Moore; H A Austin; James E Balow; T T Antonovych; C B Wilson
Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors.
Medicine 1985;64(4):219-27.
1985: K M Joyce; HA Austin; James E Balow
The patient with lupus nephritis: a nursing perspective.
Heart & lung : the journal of critical care 1985;14(1):75-9.
1984: James E Balow; HA Austin; L R Muenz; K M Joyce; T T Antonovych; JOHN KLIPPEL; A D Steinberg; Paul H Plotz; J L Decker
Effect of treatment on the evolution of renal abnormalities in lupus nephritis.
The New England journal of medicine 1984;311(8):491-5.
1984: HA Austin; L R Muenz; K M Joyce; T T Antonovych; James E Balow
Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.
Kidney international 1984;25(4):689-95.
1983: S Carette; JOHN KLIPPEL; J L Decker; HA Austin; Paul H Plotz; A D Steinberg; James E Balow
Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up.
Annals of internal medicine 1983;99(1):1-8.
1983: N Wei; JOHN KLIPPEL; D P Huston; R P Hall; T J Lawley; James E Balow; A D Steinberg; J L Decker
Randomised trial of plasma exchange in mild systemic lupus erythematosus.
Lancet 1983;1(8314-5):17-22.
1982: H J Dinant; J L Decker; JOHN KLIPPEL; James E Balow; Paul H Plotz; A D Steinberg
Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis.
Annals of internal medicine 1982;96(6 Pt 1):728-36.
1981: G C Tsokos; James E Balow
Cytotoxic responses to alloantigens in systemic lupus erythematosus.
Journal of clinical immunology 1981;1(4):208-16.